Marked Differences in C9orf72 Methylation Status and Isoform Expression between C9/ALS Human Embryonic and Induced Pluripotent Stem Cells
Open Access
- 20 October 2016
- journal article
- research article
- Published by Elsevier in Stem Cell Reports
- Vol. 7 (5) , 927-940
Abstract
No abstract availableKeywords
Funding Information
- ALS Association (16-IIP-256)
- Israel Science Foundation (0621/02)
- Mirsky foundation
- Canadian Consortium on Neurodegeneration in Aging
- Weston Brain Institute
This publication has 43 references indexed in Scilit:
- Retention of hexanucleotide repeat-containing intron in C9orf72 mRNA: implications for the pathogenesis of ALS/FTDActa Neuropathologica Communications, 2016
- The C9orf72 repeat expansion itself is methylated in ALS and FTLD patientsActa Neuropathologica, 2015
- Nuclear accumulation of mRNAs underlies G4C2 repeat-induced translational repression in a cellular model of C9orf72 ALSJournal of Cell Science, 2015
- Epigenetic Characterization of the FMR1 Promoter in Induced Pluripotent Stem Cells from Human Fibroblasts Carrying an Unmethylated Full MutationStem Cell Reports, 2014
- Hypermethylation of the CpG-island near the C9orf72 G4C2-repeat expansion in FTLD patientsHuman Molecular Genetics, 2014
- Intrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor NeuronsCell Reports, 2014
- Hexanucleotide Repeats in ALS/FTD Form Length-Dependent RNA Foci, Sequester RNA Binding Proteins, and Are NeurotoxicCell Reports, 2013
- C9ORF72 transcription in a frontotemporal dementia case with two expanded allelesNeurology, 2013
- RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense InterventionNeuron, 2013
- Differential Modeling of Fragile X Syndrome by Human Embryonic Stem Cells and Induced Pluripotent Stem CellsCell Stem Cell, 2010